AU3760400A - Methods and reagents for the diagnosis and treatment of multiple sclerosis - Google Patents
Methods and reagents for the diagnosis and treatment of multiple sclerosisInfo
- Publication number
- AU3760400A AU3760400A AU37604/00A AU3760400A AU3760400A AU 3760400 A AU3760400 A AU 3760400A AU 37604/00 A AU37604/00 A AU 37604/00A AU 3760400 A AU3760400 A AU 3760400A AU 3760400 A AU3760400 A AU 3760400A
- Authority
- AU
- Australia
- Prior art keywords
- reagents
- diagnosis
- treatment
- methods
- multiple sclerosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56927—Chlamydia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/295—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Chlamydiales (o)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/285—Demyelinating diseases; Multipel sclerosis
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12559899P | 1999-03-19 | 1999-03-19 | |
| US60125598 | 1999-03-19 | ||
| US17694000P | 2000-01-18 | 2000-01-18 | |
| US17678400P | 2000-01-18 | 2000-01-18 | |
| US17666200P | 2000-01-18 | 2000-01-18 | |
| US60176662 | 2000-01-18 | ||
| US60176784 | 2000-01-18 | ||
| US60176940 | 2000-01-18 | ||
| PCT/US2000/007226 WO2000057187A2 (en) | 1999-03-19 | 2000-03-17 | Diagnosis and treatment of multiple sclerosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3760400A true AU3760400A (en) | 2000-10-09 |
Family
ID=27494587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU37604/00A Abandoned AU3760400A (en) | 1999-03-19 | 2000-03-17 | Methods and reagents for the diagnosis and treatment of multiple sclerosis |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1166117A2 (en) |
| AU (1) | AU3760400A (en) |
| WO (1) | WO2000057187A2 (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2774959C (en) | 2000-08-04 | 2016-05-31 | Dmi Biosciences, Inc. | Method of using diketopiperazines and composition containing them |
| EP2332550A1 (en) * | 2001-07-13 | 2011-06-15 | Paratek Pharmaceuticals, Inc. | Tetracyclines for the treatment of neurodegenerative diseases |
| CA2500652A1 (en) * | 2002-10-02 | 2004-04-15 | Dmi Biosciences, Inc. | Diagnosis and monitoring of diseases |
| JP2007500747A (en) | 2003-05-15 | 2007-01-18 | ディーエムアイ バイオサイエンシズ インコーポレイテッド | Treatment of T cell mediated diseases |
| JP5856843B2 (en) | 2008-05-27 | 2016-02-10 | アンピオ ファーマシューティカルズ，インコーポレイテッド | Pharmaceutical composition using diketopiperazine |
| CA2810844C (en) | 2010-09-07 | 2017-03-21 | Dmi Acquisition Corp. | Diketopiperazine compositions for the treatment of metabolic syndrome and related conditions |
| SG10201608087WA (en) | 2011-10-10 | 2016-11-29 | Ampio Pharmaceuticals Inc | Implantable medical devices with increased immune tolerance, and methods for making and implanting |
| EP2766029B1 (en) | 2011-10-10 | 2020-03-25 | Ampio Pharmaceuticals, Inc. | Treatment of degenerative joint disease |
| MX355446B (en) | 2011-10-28 | 2018-04-18 | Ampio Pharmaceuticals Inc | Treatment of rhinitis. |
| CA2906864A1 (en) | 2013-03-15 | 2014-09-18 | Ampio Pharmaceuticals, Inc. | Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same |
| KR20170045274A (en) | 2014-08-18 | 2017-04-26 | 앰피오 파마슈티컬스 인코퍼레이티드 | Treatment of joint conditions |
| US11389512B2 (en) | 2015-06-22 | 2022-07-19 | Ampio Pharmaceuticals, Inc. | Use of low molecular weight fractions of human serum albumin in treating diseases |
| CN109453165B (en) * | 2018-10-16 | 2021-02-05 | 丹诺医药(苏州）有限公司 | Solid dispersion of rifamycin-nitroimidazole coupled molecule and application thereof |
| US11116737B1 (en) | 2020-04-10 | 2021-09-14 | University Of Georgia Research Foundation, Inc. | Methods of using probenecid for treatment of coronavirus infections |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2134292A1 (en) * | 1971-04-30 | 1972-12-08 | Inst Nat Sante Rech Med | Interferon compsns - contg halo desoxyuridines rifamycine or rifampycine |
| US3996355A (en) * | 1975-01-02 | 1976-12-07 | American Home Products Corporation | Permanent suspension pharmaceutical dosage form |
| IE65771B1 (en) * | 1990-01-25 | 1995-11-15 | Zeneca Ltd | Amplification of nucleotide sequences using vectorette units |
| US5217493A (en) * | 1992-03-11 | 1993-06-08 | Board Of Regents, The University Of Texas System | Antibacterial coated medical implants |
| DE69400631T2 (en) * | 1993-05-05 | 1997-02-27 | Palo Alto Medical Found | USE OF RIFAMYCINE DERIVATIVES FOR PRODUCING A MEDICINAL PRODUCT FOR TREATING TOXOPLASMOSIS |
| CN1069196C (en) * | 1996-02-09 | 2001-08-08 | 王成武 | Application of rifampicin in linxiao'an medicine for treating gonorrhea |
| AU4151697A (en) * | 1996-08-14 | 1998-03-06 | Vanderbilt University | Compositions of antichlamydial agents for the diagnosis and management of infection caused by (chlamydia) |
| US5795563A (en) * | 1996-09-04 | 1998-08-18 | Sphingomonas Research Partners, L.P. | Identification of an exogenous intra-erythrocytic bacterium in patients having systemic lupus erythematosus, and treatment |
| US6464979B1 (en) * | 1996-09-12 | 2002-10-15 | Aventis Pasteur Limited | Chlamydial vaccines and methods of preparation thereof |
| ES2293678T3 (en) * | 1997-05-06 | 2008-03-16 | Vanderbilt University | COMPOSITIONS OF ANTI-CLAMID AGENTS FOR DIAGNOSIS AND INFECTION TREATMENT CAUSED BY CLAMIDIAS. |
| CN1190581A (en) * | 1998-02-25 | 1998-08-19 | 高绪侠 | Complex rifampin injection |
| AUPP437698A0 (en) * | 1998-06-30 | 1998-07-23 | Baumgart, Karl | Methods for treatment of coronary, carotid and other vascular disease |
-
2000
- 2000-03-17 EP EP00916513A patent/EP1166117A2/en not_active Withdrawn
- 2000-03-17 AU AU37604/00A patent/AU3760400A/en not_active Abandoned
- 2000-03-17 WO PCT/US2000/007226 patent/WO2000057187A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1166117A2 (en) | 2002-01-02 |
| WO2000057187A9 (en) | 2001-10-25 |
| WO2000057187A2 (en) | 2000-09-28 |
| WO2000057187A3 (en) | 2001-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2815900A (en) | Clinical and diagnostic database | |
| AU4690699A (en) | Apparatus and methods for entering cavities of the body | |
| AU4205100A (en) | Methods and compositions for the treatment of pancreatitis | |
| AU2124397A (en) | Compositions and methods for the treatment and diagnosis of cardiovascular disease | |
| AU2002225219A1 (en) | Diagnosis and treatment of multiple sclerosis | |
| AU2681999A (en) | Compounds and methods for diagnosis of tuberculosis | |
| AU2002219229A1 (en) | Means for the diagnosis and therapy of CTCL | |
| AU1575697A (en) | Compositions and methods for the treatment and diagnosis of cancer | |
| AU3760400A (en) | Methods and reagents for the diagnosis and treatment of multiple sclerosis | |
| AU2002240336A1 (en) | Methods for the diagnosis and treatment of tumors employing the hepsin gene | |
| EP1144639A3 (en) | Compounds and methods for the diagnosis and treatment of ehrlichia infection | |
| AU5116100A (en) | Connector and method of use of the connector | |
| AU6425800A (en) | Agents for the diagnosis, prognosis and treatment of malignant diseases | |
| AU6366100A (en) | Novel methods and reagents for the treatment of osteoarthritis | |
| AU6786898A (en) | Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders | |
| AU4204700A (en) | Compounds and methods for the diagnosis and treatment of (b. microti) infection | |
| AU1820499A (en) | Compounds and methods for the diagnosis and treatment of (b. microti) infection | |
| AU6786598A (en) | Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders | |
| GB9922710D0 (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatatives for the treatment of multiple sclerosis | |
| AU2566201A (en) | Compounds and methods for the treatment of pain | |
| AU2001287007A1 (en) | Reagents and methods for the diagnosis of cmv dissemination | |
| AU6786798A (en) | Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders | |
| AU8580598A (en) | Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders | |
| AU6509698A (en) | Methods for clinical diagnosis | |
| AU6653698A (en) | Use of the p-ten suppressor gene in diagnosis and treatment of cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |